FR2706303B1 - Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson. - Google Patents

Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.

Info

Publication number: FR2706303B1
Authority: FR; France
Prior art keywords: efaroxan; parkinson; disease; derivatives; preparation
Prior art date: 1993-06-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

FR9307379A

Other languages

English (en)

French (fr)

Other versions

FR2706303A1 (fr

Inventor

Colpaert Francis

Briley Michael

Imbert Thierry

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pierre Fabre Medicament SA

Original Assignee

Pierre Fabre Medicament SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-06-18

Filing date

1993-06-18

Publication date

1995-09-08

1993-06-18 Priority to FR9307379A priority Critical patent/FR2706303B1/fr

1993-06-18 Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA

1994-06-15 Priority to JP50249995A priority patent/JP3394257B2/ja

1994-06-15 Priority to DE69424415T priority patent/DE69424415T2/de

1994-06-15 Priority to PCT/FR1994/000715 priority patent/WO1995000145A1/fr

1994-06-15 Priority to CA002165437A priority patent/CA2165437A1/fr

1994-06-15 Priority to DK94919712T priority patent/DK0703781T3/da

1994-06-15 Priority to ES94919712T priority patent/ES2147576T3/es

1994-06-15 Priority to PT94919712T priority patent/PT703781E/pt

1994-06-15 Priority to NZ268039A priority patent/NZ268039A/xx

1994-06-15 Priority to EP94919712A priority patent/EP0703781B1/de

1994-06-15 Priority to AT94919712T priority patent/ATE192650T1/de

1994-06-15 Priority to AU70764/94A priority patent/AU689783B2/en

1994-06-16 Priority to ZA944281A priority patent/ZA944281B/xx

1994-12-23 Publication of FR2706303A1 publication Critical patent/FR2706303A1/fr

1995-09-08 Application granted granted Critical

1995-09-08 Publication of FR2706303B1 publication Critical patent/FR2706303B1/fr

1997-03-26 Priority to US08/825,414 priority patent/US5948806A/en

2000-07-28 Priority to GR20000401754T priority patent/GR3034062T3/el

2013-06-18 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

FR9307379A 1993-06-18 1993-06-18 Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson. Expired - Lifetime FR2706303B1 (fr)

Priority Applications (15)

Application Number	Priority Date	Filing Date	Title
FR9307379A FR2706303B1 (fr)	1993-06-18	1993-06-18	Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.
AT94919712T ATE192650T1 (de)	1993-06-18	1994-06-15	Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
PCT/FR1994/000715 WO1995000145A1 (fr)	1993-06-18	1994-06-15	Utilisation de l'efaroxan et de ses derives pour la preparation d'un medicament destine au traitement de la maladie de parkinson
CA002165437A CA2165437A1 (fr)	1993-06-18	1994-06-15	Utilisation de l'efaroxan et de ses derives pour la preparation d'un medicament destine au traitement de la maladie de parkinson
DK94919712T DK0703781T3 (da)	1993-06-18	1994-06-15	Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom
ES94919712T ES2147576T3 (es)	1993-06-18	1994-06-15	Utilizacion del efaroxan y de sus derivados para la preparacion de un medicamento destinado al tratamiento de la enfermedad de parkinson.
PT94919712T PT703781E (pt)	1993-06-18	1994-06-15	Utilizacao de efaroxan e dos seus derivados para a preparacao de um medicamento destinado ao tratamento da doenca de parkinson
NZ268039A NZ268039A (en)	1993-06-18	1994-06-15	Use of efaroxan in treating parkinson's disease
JP50249995A JP3394257B2 (ja)	1993-06-18	1994-06-15	パーキンソン病の治療を目的とする医薬品の製造のためのエファロキサンおよびその誘導体の使用
DE69424415T DE69424415T2 (de)	1993-06-18	1994-06-15	Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
AU70764/94A AU689783B2 (en)	1993-06-18	1994-06-15	Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of Parkinson disease
EP94919712A EP0703781B1 (de)	1993-06-18	1994-06-15	Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
ZA944281A ZA944281B (en)	1993-06-18	1994-06-16	Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease
US08/825,414 US5948806A (en)	1993-06-18	1997-03-26	Treatment of Parkinson's disease with (+)2-(ethyl-2,3-dihydrobenzofuranyl)-2-Imidazoline (dexefaroxan or (+) efaroxan)
GR20000401754T GR3034062T3 (en)	1993-06-18	2000-07-28	Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9307379A FR2706303B1 (fr)	1993-06-18	1993-06-18	Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.

Publications (2)

Publication Number	Publication Date
FR2706303A1 FR2706303A1 (fr)	1994-12-23
FR2706303B1 true FR2706303B1 (fr)	1995-09-08

Family

ID=9448287

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR9307379A Expired - Lifetime FR2706303B1 (fr)	1993-06-18	1993-06-18	Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.

Country Status (15)

Country	Link
US (1)	US5948806A (de)
EP (1)	EP0703781B1 (de)
JP (1)	JP3394257B2 (de)
AT (1)	ATE192650T1 (de)
AU (1)	AU689783B2 (de)
CA (1)	CA2165437A1 (de)
DE (1)	DE69424415T2 (de)
DK (1)	DK0703781T3 (de)
ES (1)	ES2147576T3 (de)
FR (1)	FR2706303B1 (de)
GR (1)	GR3034062T3 (de)
NZ (1)	NZ268039A (de)
PT (1)	PT703781E (de)
WO (1)	WO1995000145A1 (de)
ZA (1)	ZA944281B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6281207B1 (en) *	1999-09-15	2001-08-28	Reed Richter	Treatment of movement disorders by administration of mirtazapine
FR2814368B1 (fr) *	2000-09-26	2004-05-07	Pf Medicament	Preparation pharmaceutique a base d'oxans
DE60134659D1 (de) *	2000-11-14	2008-08-14	Orion Corp	Vorbeugung der entwicklung von dyskinesie
US8188126B2 (en)	2002-05-16	2012-05-29	Pierre Fabre Medicament	Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
US9463186B2 (en)	2013-04-15	2016-10-11	Northwestern University	Treatment for dopaminergic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZW13782A1 (en) *	1981-07-28	1982-10-06	Reckitt & Colmann Prod Ltd	Imidazoline derivatives
FR2669030B1 (fr) *	1990-11-14	1992-12-31	Adir	Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5281607B1 (en) *	1992-10-08	1998-05-19	Univ New York	Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases

1993
- 1993-06-18 FR FR9307379A patent/FR2706303B1/fr not_active Expired - Lifetime
1994
- 1994-06-15 AT AT94919712T patent/ATE192650T1/de not_active IP Right Cessation
- 1994-06-15 PT PT94919712T patent/PT703781E/pt unknown
- 1994-06-15 ES ES94919712T patent/ES2147576T3/es not_active Expired - Lifetime
- 1994-06-15 EP EP94919712A patent/EP0703781B1/de not_active Expired - Lifetime
- 1994-06-15 NZ NZ268039A patent/NZ268039A/xx unknown
- 1994-06-15 CA CA002165437A patent/CA2165437A1/fr not_active Abandoned
- 1994-06-15 AU AU70764/94A patent/AU689783B2/en not_active Ceased
- 1994-06-15 DK DK94919712T patent/DK0703781T3/da active
- 1994-06-15 DE DE69424415T patent/DE69424415T2/de not_active Expired - Fee Related
- 1994-06-15 WO PCT/FR1994/000715 patent/WO1995000145A1/fr active IP Right Grant
- 1994-06-15 JP JP50249995A patent/JP3394257B2/ja not_active Expired - Fee Related
- 1994-06-16 ZA ZA944281A patent/ZA944281B/xx unknown
1997
- 1997-03-26 US US08/825,414 patent/US5948806A/en not_active Expired - Fee Related
2000
- 2000-07-28 GR GR20000401754T patent/GR3034062T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE192650T1 (de)	2000-05-15
EP0703781B1 (de)	2000-05-10
JP3394257B2 (ja)	2003-04-07
DE69424415D1 (de)	2000-06-15
JPH09500375A (ja)	1997-01-14
FR2706303A1 (fr)	1994-12-23
US5948806A (en)	1999-09-07
CA2165437A1 (fr)	1994-12-19
DK0703781T3 (da)	2000-10-02
AU7076494A (en)	1995-01-17
ES2147576T3 (es)	2000-09-16
DE69424415T2 (de)	2000-12-21
AU689783B2 (en)	1998-04-09
NZ268039A (en)	1999-06-29
WO1995000145A1 (fr)	1995-01-05
ZA944281B (en)	1995-02-10
EP0703781A1 (de)	1996-04-03
GR3034062T3 (en)	2000-11-30
PT703781E (pt)	2000-10-31

Similar Documents

Publication	Publication Date	Title
AU9125798A (en)	1999-03-16	Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
HUP9902105A2 (hu)	1999-09-28	Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása
FR2700117B1 (fr)	1995-02-03	Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
IL97446A0 (en)	1992-06-21	Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens
NO302523B1 (no)	1998-03-16	Heterosykliske forbindelser, farmasöytiske preparater som omfatter dem, og anvendelse av forbindelsene for fremstilling av medikamenter
IL86423A0 (en)	1988-11-15	Pharmaceutical compositions for the treatment of alzheimer's disease
BG104179A (en)	2000-10-31	Phanquinon administration for the treatment of the alzheimer's disease
FR2712495B1 (fr)	1996-01-05	Application de l'Óoenotheine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, et les compositions pharmaceutiques le contenant.
FR2706303B1 (fr)	1995-09-08	Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.
EP0305276A3 (de)	1990-07-25	Verwendung von 2-Amino-6-trifluormethoxybenzthiazol zur Herstellung eines Arzneimittels zur Behandlung von Schizophrenie
FR2397391A1 (fr)	1979-02-09	Alpha-halogenomethyl-phenylalanines et leurs derives, leur preparation et leur utilisation comme medicaments, notamment pour traiter la maladie de parkinson ou un etat de psychose
OA09665A (fr)	1993-05-15	Esters d'aminoacides de l'hydroquinone, leur procédé de préparation et compositions pharmaceutiques ou cosmétiques les contenant
FR2718024B1 (fr)	1996-06-21	Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2699535B1 (fr)	1995-03-17	Dérivés de l'étoposide, leur procédé de préparation, leur utilisation à titre de médicament et leur utilisation pour la préparation d'un médicament destiné au traitement anticancéreux.
FR2698789B1 (fr)	1995-03-03	Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
ZA924128B (en)	1993-03-25	New combination preparations for treatment of Parkinson's disease.
FR2707166B1 (fr)	1995-09-29	Utilisation de l'efaroxan et de ses dérivés pour la fabrication de médicaments destinés au traitement de maladies neurodégénératives et leur progression .
FR2713087B1 (fr)	1996-02-23	Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.
FR2673105B1 (fr)	1995-01-13	Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
HUP0004647A2 (hu)	2001-05-28	Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
BE1003340A3 (fr)	1992-03-03	Nouvelle utilisation therapeutique des alpha-aminofluorocetones.
FR2691064B3 (fr)	1996-01-12	Nouveau medicament pour le traitement de l'arythmie.
CA2217463A1 (fr)	1998-04-04	Utilisation de la sulbutiamine pour l'obtention de compositions pharmaceutiques utiles dans le traitement de certains troubles psychomoteurs et psycho-intellectuels
FR2652747B1 (fr)	1995-03-31	Application d'agents actifs pour la preparation d'un medicament destine au traitement de maladies auto-immunes.
FR2713088B1 (fr)	1996-03-22	Utilisation de la vitamine B1 et ses dérivés pour la préparation d'un médicament destiné au traitement des affections dont les symptômes sont attribués aux désordres d'origine vasculaire.